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Lemierre’s Syndrome, A Case Report and Review of Literature
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Abstract
Lemierre’s syndrome is a suppurative thrombophlebitis of the internal jugular vein. In this paper
we describe a case of severe Lemierre’s syndrome in a healthy 18 year-old woman. She initially
presented with sore throat, and failed outpatient antibiotic therapy. She quickly progressed to
septic shock, internal jugular vein septic thrombophlebitis, septic pulmonary emboli, empyema and
respiratory failure. Successful treatment included intravenous antibiotics and thoracotomy. It is a
rare disease that has been kept at bay with the widespread use of antibiotics for upper respiratory
infections. However, in recent years there seems to be an increase in the number of cases being
reported which some have attributed to increased adherence to antimicrobial stewardship.
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Introduction
Lemierre’s syndrome is a pyogenic or septic thrombophlebitis
of the internal jugular vein. It is a rare condition that typically
starts as pharyngitis that spreads locally and leads to
suppurative inflammation in and around the internal jugular
vein leading to thrombosis of the vein [1]. The most commonly
associated pathogen is the anaerobic gram-negative bacteria,
Fusobacterium necrophorum [2]. However, other pathogens
have been identified in this kind of infection. It is associated with
significant morbidity and mortality on account of the frequently
associated septic emboli from the internal jugular vein to the
lungs and overwhelming anaerobic sepsis. This disease for
unclear reason tends to occur in young, healthy individuals with
no other identifiable risk factors. Fusobacterium necrophorum
is a part of the normal gastrointestinal/genitourinary flora
of humans. The disease is treated with a combination of IV
antibiotics during inpatient treatment with continued longterm antibiotics after discharge. There is a possibility of
surgery to resect the thrombus and affected vascular structures
in combination with anticoagulants. The syndrome is often
misdiagnosed until bacteremia is identified and the patient
begins to decompensate rapidly. In this report we present the
case of a young female who presented with anaerobic gramnegative sepsis and cavitary pneumonia rapidly progressing to
empyema and respiratory failure requiring thoracotomy with
decortication. Although there is a positive outcome in this case,

it is important to be mindful of this potentially deadly disease
when evaluating any young person presenting with anaerobic
sepsis.

Case Report
An 18 year old female presented to a walk-in clinic for sore
throat of three days duration and was diagnosed empirically
with streptococcal pharyngitis. She was sent home on five
days of azithromycin. Seven days later, she presented to the
emergency department with worsening symptoms of dyspnea,
fever, chills, sharp left anterior chest pain, emesis, diarrhea
and mental confusion. She reported some improvement in her
sore throat following treatment with azithromycin. She smokes
about half-pack of cigarettes every day and denies any illicit drug
or alcohol use. There was no history of previous hospitalization
or any major surgeries in the past, and she was not on any
medications. On evaluation in the ED, patient appeared acutely
ill. Her vital signs on arrival were temperature of 38.1o°C,
respiratory rate of 38/min, heart rate of 168 beats/min, blood
pressure of 113/61 mmHg, and 92% O2 saturation on room air.
On physical examination the abnormal findings were dry oral
mucous membranes, diminished breath sounds bilaterally, and
a swollen left wrist that was tender to palpation. Initial chest
x-ray showed a left lower lobe infiltrate.
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Figure 1. Ultrasound showing the thrombus in the internal jugular. Ultrasound (right) showing no flow in the internal jugular vein

Figure 2. Progressive CT images w/ contrast showing the thrombus (in red)

Labs had normal WBC of 9.26 x 103 L with elevated neutrophils
of 8.9 x 103 L and low platelets count of 79 x 103 L with lactic acid
of 3.3 (venous draw). She also showed signs of liver dysfunction
with ALT of 69 U/L, AST 92 U/L, Albumin 2.8 g/dL. An initial
diagnosis of left lower lobe pneumonia with possible sepsis
causing thrombocytopenia was made. Blood and sputumcultures were drawn and sent to lab. She was admitted to the
ICU and started on intravenous fluid resuscitation, albuterol,
ipratropium, ceftriaxone, ketorolac, and acetaminophen.
Her CT scan showed bibasilar pneumonia with effusions and
splenomegaly.
Antibiotics were changed on day two to piperacillin- tazobactam
when her anaerobic blood culture bottle came up positive
showing gram-negative rods. The patient continued to decline
with new onset of hemoptysis, worsening dyspnea, drop in
hemoglobin to 8.6 g/dL, firm and tender abdomen, undulating
fevers, and further effusion in the lungs on x-ray. Thoracentesis
was performed with lavage to break up loculations, and
levofloxacin was added to her antibiotic management on day
three. The left upper extremity swelling worsened warranting
further examination. Ultrasound (Figure 1) found a
parapharyngeal abscess about 1.5 cm in diameter, and occlusion
of the left internal jugular vein was suspected and verified with

of Lemierre’s syndrome was confirmed. Levofloxacin was
discontinued, but piperacillin-tazobactam was continued.
Anticoagulation was considered because of the extent of her
vascular clotting and left upper extremity swelling but held
due to inconclusive evidence it would improve the situation.
However, she was on enoxaparin for DVT prophylaxis.
Chest tube lavage was done again to break up loculations, and
the tube was exchanged for a larger caliber version with more
drainage ports. Between day four and day five, her fever spikes
worsened and she was intubated because of hypoxic respiratory
failure. Repeat CT scan on day five, (Figure 3) showed multiple
septic pulmonary emboli within the lungs.
On day six, patient underwent thoracotomy with decortication.
Multiple cavitary lesions were found and unroofed during
the procedure. She was kept on piperacillin-tazobactam
and under sedation/ventilation until the following day. Her
clinical condition began to improve on day eight, x-ray showed
improvement with better lung inflation.
Her fevers subsided, and patient was transferred out of ICU.
She was subsequently discharged home on IV ertapenem for 30
days on outpatient parenteral antibiotic therapy through home
health and followed up at an outpatient clinic.

CT scan of the neck (Figure 2). Occlusion began at the angle of
mandible and extended to the subclavian vein.
Blood cultures were later identified as Fusobacterium
necrophorum (F. necrophorum) on day four, and a diagnosis
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Figure 3. Angiography on left and CT on right

Review of Literature

ratio is variable. Some reports put it at 1:1 [4] and a review by
Kerkos reported a male to female ratio of 2:1 [5]; our summary
view of the literature had a ratio of 1.8:1.

Epidemiology
Lemierre’s syndrome is described as a disease originating
from the oropharynx and leading to thrombophlebitis of the
internal jugular vein, anaerobic bacteremia and septic emboli
to distant sites such as the lungs [2]. It was first described by
Lemierre in 1936 [3]. It is a relatively rare infectious syndrome
commonly found in otherwise healthy young adults. However,
extensive review of 179 published papers (from 2007 to 2018)
indicates that ages may range from 5 weeks to 86 years old with
the median age still in the second decade of life (Figure 4). It
appears to develop as a complication of an upper respiratory
bacterial infection. Although it is still considered a rare disease
with an incidence of less than 4 per 1 million population [4]
some have noticed an uptick in cases possibly due to antibiotic
resistance or changes in prescription habits [5].

Figure 4. Histogram of cases by age 2007-2018 sampling

To date nearly 700 articles have been published related to
Lemierre’s Syndrome with averages of 8/year from 1950 to
1990, 81/year from 1991 to 2000, 290/year from 2001 to 2010
and 311/year since 2011 (Figure 5). It is not known whether the
increase in case reports is as a result of true increase in incidence
or merely an accident of more people willing to publish details
of their cases. There is however some circumstantial evidence
of rising incidence owing primarily to rising incidence of F.
necrophourm bacteremia and other bacterial etiologies [6].S
It has been speculated that an increase in incidence might
be as a result of the hesitation of primary care providers to
prescribe antibiotics for common upper respiratory tract
infections due to emphasis on antimicrobial stewardship [7,8].
Also, changes in prescription patterns whereby antibiotics that
are effective against F. necrophorum such as penicillin are no
longer considered first line agents for URIs due to widespread
resistance, rather other antibiotics such as azithromycin that
has no activity against anaerobes are now given as first line
agents when antibiotics are prescribed for pharyngitis and other
URIs [9] such as was the case in our patient. The male to female

Figure 5. Search results of PubMed database for Lemeirre’s Syndrome
and results broken down by year

Pathophysiology
Fusobacterium necrophorum is the most common bacterium
associated with Lemierre’s Syndrome [5]. F. necrophorum is
an anaerobic gram-negative rod that is commonly found in the
oropharynx. It is normal flora of the oral cavity, gastrointestinal
tract and the female genital tract [2]. It has been implicated in
cases of tonsillitis (87% of LS) or mastoiditis (3% of LS) [7,10].
Other bacterial etiologies include other Fusobacterium species,
F. nucleatum, Bacteroides species, Prevotella species [2,5],
Streptococcus species [11], Staphylococcus species [12], Slackia
[13], Porphyomonas [14], methicillin-resistant staphylococcus
epidermidis [15], methicillin-sensitive staphylococcus aureus
[16], methicillin-resistant staphylococcus aureus [17], Klebsiella
[18], Chromobacterium [19], Acranobacterium [20]. Infection
usually begins in the oropharynx but spreads to peritonsillar
tissue and to the parapharyngeal space via the lymphatics.
This then leads to inflammation of the endothelial lining of
the internal jugular vein resulting in thrombosis and later
suppuration of the clotted vessel. Subsequent bacteremia leads
to metastatic infection to the lungs, liver, kidney and joints [21].
Clinical Presentation
The clinical presentation of LS is variable depending on the
extent of infection and distant metastasis. Lemierre’s syndrome
usually presents as fever, neck pain, swelling, and dyspnea about
three days to four weeks after a sore throat, average seven days
[2,22]. Physical symptoms may resolve at the site of original
infection; however, the patient may present with sore throat,
dysphagia and dysphonia, ear ache and otorrhea, pleuritic chest
pain and dyspnea one week later. There may be joint pain and
swelling in cases of joint involvement. Tenderness behind the
ear may be noted in patients whose infections originated from
mastoiditis. But by far the commonest presentations are fever,
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unilateral neck pain and swelling with other signs of sepsis.
Sometimes IJV thrombosis is identified incidentally during
workup for neck pain or pharyngitis, and septicemia will usually
begin to happen a week after onset. Spread of the infection to the
lungs is common in a majority of patients [23]. Liver enzymes
can be elevated, but the reason for this is not completely
understood. Diagnosis should be made with positive cultures
and either ultrasound or CT imaging with contrast.

5.

6.

7.

Treatment
Intravenous antibiotic is the cornerstone of treatment. F.
necrophrum can produce B-lactamase, but it is generally
susceptible to penicillin, second and third generation
cephalosporins, clindamycin, metronidazole, B-lactamB-lactamase combination antibiotics such as piperacillintazobactam, ampicillin-sulbactam, and carbapenems [2].
Treatment can vary widely depending on the extent of infection
[24]. Surgery may be required in cases of empyema or lung
abscesses. Arthrotomy may be necessary in cases of septic
arthritis. Even though results of treatment might not be
immediate, it is important to continue IV antibiotics for up to six
weeks [6]. In some cases, drainage of the abscess and/or internal
jugular excision is needed if antibiotic therapy is not effective at
eliminating the infection [25,26]. Ligation and excision of the
IJV, which was the treatment modality in the pre-antibiotic era,
is no longer being practiced. There is also some controversy
on the role of anticoagulation use in this disease. The role of
anticoagulation in the management of LS is limited to certain
situations where thrombosis has extended to the great vessels in
the chest or to intracranial venous channels [27,28,29].

8.

9.
10.

11.

12.

13.

Conclusion
Lemierre’s syndrome is a severe suppurative intravascular
infection of the neck that is associated with a high morbidity and
some mortality if not identified in time. Patients with unusual
neck masses with upper respiratory infections or in the week
proceding that should be evaluated immediately for LS so that
appropriate treatment can be promptly initiated.
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